Cardiex Ltd
ASX:CDX
Cardiex Ltd
ASX:CDX
Price:
0.054 AUD
1.89%
Market Closed
Updated:
May 5, 2024
Cardiex Ltd
Gross Profit
|
Cardiex Ltd
Gross Profit Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cardiex Ltd
ASX:CDX
|
Gross Profit
AU$12m
|
CAGR 3-Years
41%
|
CAGR 5-Years
31%
|
CAGR 10-Years
9%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Gross Profit
AU$1.3m
|
CAGR 3-Years
259%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Gross Profit
AU$9.1m
|
CAGR 3-Years
24%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Gross Profit
AU$17.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Cochlear Ltd
ASX:COH
|
Gross Profit
AU$1.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cardiex Ltd's Gross Profit?
Gross Profit
12m
AUD
12m
AUD
Based on the financial report for Dec 31, 2023, Cardiex Ltd's Gross Profit amounts to 12m AUD.
What is Cardiex Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
9%
9%
Over the last year, the Gross Profit growth was 312%. The average annual Gross Profit growth rates for Cardiex Ltd have been 41% over the past three years , 31% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
